Brian Pandya is Partner at Duane Morris LLP. A member of the firm’s Trial Practice Group, Brian represents technology, manufacturing, and healthcare companies in high-stakes litigation, arbitrations, investigations and appeals. He has served as lead trial counsel in a range of intellectual property, antitrust, complex commercial and white-collar matters. He also regularly counsels clients on cybersecurity and national security issues, particularly matters concerning emerging technologies and artificial intelligence.
Before joining Duane Morris, Brian served at the U.S. Department of Justice as Deputy Associate Attorney General from 2019-21, where he oversaw investigations and litigation undertaken by the Antitrust Division and Civil Division, reviewed Torts Branch settlements, and served on several high-profile task forces and trial teams. Brian was also previously a litigation and IP partner at another prominent Washington, DC firm.
Brian clerked for Judge Leonard Davis on the United States District Court for the Eastern District of Texas. He is a two-time recipient of the Federal Circuit Bar Association’s Pro Bono Advocacy Award for work on behalf of military veterans and has served as volunteer federal public defender in the Eastern District of Virginia, among many other bar and community engagements.
*****
A person listed as a contributor has spoken or otherwise participated in Federalist Society events, publications, or multimedia presentations. A person's appearance on this list does not imply any other endorsement or relationship between the person and the Federalist Society. In most cases, the biographical information on a person's "contributor" page is provided directly by the person, and the Federalist Society does not edit or otherwise endorse that information. The Federalist Society takes no position on particular legal or public policy issues. All expressions of opinion by a contributor are those of the contributor.
An Unconventional View of Intellectual Property and Antitrust Policy — A Fireside Chat with Prof. Jonathan Barnett
The Mayflower Hotel1127 Connecticut Ave NW
Washington, DC 20036
Four Years Later, Did the "New Madison Approach" to IP and Antitrust Promote Innovation?
A Regulatory Transparency Project Webinar
TeleforumYou've Got a FRAND in Me: FTC v. Qualcomm's Implications for IP Law and the Fair, Reasonable, and Non-Discriminatory Standard
Michigan Student Chapter
Zoom Webinar -- University of MichiganVirtual
Ann Arbor, MI 48109
Courthouse Steps: SAS Institute Inc. v. Iancu Decided
Intellectual Property Practice Group and Regulatory Transparency Project Teleforum
TeleforumAn Unconventional View of Intellectual Property and Antitrust Policy — A Fireside Chat with Prof. Jonathan Barnett
Join us on Thursday, February 27th at 12:00 PM ET for a special lunch panel sponsored by our Intellectual Property Practice...
Does Jarkesy Doom the Preserve Access to Affordable Generics and Biosimilars Act?
Reducing the cost of prescription drugs has been a bipartisan priority for years. One recent...
Does Jarkesy Doom the Preserve Access to Affordable Generics and Biosimilars Act?
Reducing the cost of prescription drugs has been a bipartisan priority for years. One recent...
Deep Dive Episode 219 – Four Years Later, Did the “New Madison Approach” to IP and Antitrust Promote Innovation?
Regulatory Transparency Project's Fourth Branch Podcast
In 2018, then-Assistant Attorney General Makan Delrahim announced with great fanfare the “New Madison Approach”...
Can Tribal Immunity Shield Blockbuster Drugs from PTAB Scrutiny?
The Patent Trial & Appeal Board, an administrative panel created as part of the America...